Medical Sciences Program, Universidade Federal do Rio Grande do Sul, Porto Alegre 90050-170, Brazil.
Biological Sciences Program, Universidade Federal do Rio Grande do Sul, Porto Alegre 90050-170, Brazil.
World J Gastroenterol. 2022 Jan 21;28(3):348-364. doi: 10.3748/wjg.v28.i3.348.
BACKGROUND: Cirrhosis is an important health problem characterized by a significant change in liver parenchyma. In animals, this can be reproduced by an experimental model of bile duct ligation (BDL). Melatonin (MLT) is a physiological hormone synthesized from serotonin that has been studied for its beneficial properties, including its antioxidant potential. AIM: To evaluate MLT's effects on oxidative stress, the inflammatory process, and DNA damage in an experimental model of secondary biliary cirrhosis. METHODS: Male Wistar rats were divided into 4 groups: Control (CO), CO + MLT, BDL, and BDL + MLT. MLT was administered (20 mg/kg) daily beginning on day 15 after biliary obstruction. On day 29 the animals were killed. Blood samples, liver tissue, and bone marrow were collected for further analysis. RESULTS: BDL caused changes in biochemical and histological parameters and markers of inflammatory process. Thiobarbituric acid (0.46 ± 0.01) reactive substance levels, superoxide dismutase activity (2.30 ± 0.07) and nitric oxide levels (2.48 ± 0.36) were significantly lower ( < 0.001) n the groups that received MLT. DNA damage was also lower ( < 0.001) in MLT-treated groups (171.6 ± 32.9) than the BDL-only group (295.5 ± 34.8). Tissue damage and the expression of nuclear factor kappa B, interleukin-1β, Nrf2, NQO1 and Hsp70 were significantly lower in animals treated with MLT ( < 0.001). CONCLUSION: When administered to rats with BDL-induced secondary biliary cirrhosis, MLT effectively restored the evaluated parameters.
背景:肝硬化是一种重要的健康问题,其特征为肝脏实质发生显著变化。在动物中,这种变化可以通过胆管结扎(BDL)的实验模型来复制。褪黑素(MLT)是一种由血清素合成的生理激素,其有益特性,包括抗氧化潜力,已得到研究。 目的:评估 MLT 对实验性继发性胆汁性肝硬化模型中氧化应激、炎症过程和 DNA 损伤的影响。 方法:雄性 Wistar 大鼠分为 4 组:对照组(CO)、CO+MLT、BDL 和 BDL+MLT。BDL 后第 15 天开始每天给予 MLT(20mg/kg)。第 29 天处死动物。采集血液样本、肝组织和骨髓进行进一步分析。 结果:BDL 引起生化和组织学参数以及炎症过程标志物的变化。硫代巴比妥酸(0.46±0.01)反应性物质水平、超氧化物歧化酶活性(2.30±0.07)和一氧化氮水平(2.48±0.36)显著降低(<0.001),接受 MLT 治疗的组。DNA 损伤也较低(<0.001),MLT 治疗组(171.6±32.9)比仅 BDL 组(295.5±34.8)。用 MLT 治疗的动物组织损伤和核因子 kappa B、白细胞介素-1β、Nrf2、NQO1 和 Hsp70 的表达显著降低(<0.001)。 结论:当给予 BDL 诱导的继发性胆汁性肝硬化大鼠时,MLT 有效恢复了评估参数。
World J Gastroenterol. 2022-1-21
World J Gastroenterol. 2005-4-7
Basic Clin Pharmacol Toxicol. 2008-4
Pharmaceuticals (Basel). 2025-4-23
World J Stem Cells. 2024-11-26
World J Nephrol. 2024-9-25
Am J Physiol Gastrointest Liver Physiol. 2024-12-1
Antioxidants (Basel). 2024-4-7
J Cell Mol Med. 2019-9-2
Gene Expr. 2019-11-4
World J Hepatol. 2019-3-27
Biochim Biophys Acta Mol Basis Dis. 2019-3-16
Int J Mol Sci. 2019-3-11